NCT06488612 Evaluation of the Use of Minced Skin Grafts for Promoting Donor Site Wound Healing After Split-Thickness Skin Grafting
| NCT ID | NCT06488612 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Traumatic Skin Loss, 2nd and 3rd Degree Burn, Post Tumour Excision - Raw Areas Undergoes Split- Thickness Skin Grafts |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-12-01 |
| Primary Completion | 2024-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2023-12-01 with a primary completion date of 2024-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Split-thickness skin grafting (STSG) is one of the most commonly performed procedures to achieve wound closure. Most studies are concerned on improving the appearance of scars and shortening the healing time of the recipient sites. However, the management of the donor site usually takes a second consideration. There is a lack of consensus on the recommended method of donor site management. Donor site morbidity of STSG is usually minimal, but that may not always be the case. Morbidity may include pigmentary abnormalities, prolonged pain and itching, delayed healing, or unfavorable scarring. So, an effort must be taken to find the optimal solution for donor site healing and minimize morbidity. Small portions of the skin graft left at the end of the procedure or the graft pieces obtained after trimming the edges are usually discarded. There have been some studies demonstrating the benefit of the minced residual skin graft on the donor site, possibly resulting in earlier epithelialization and improving the appearance
Eligibility Criteria
Inclusion Criteria: * All patients undergoing split-thickness skin grafting, between 12 - 60 years of age. Exclusion Criteria: * Patients under the age of 12 years or above 60 years. * Patients with a known tendency for hypertrophic scarring/keloids * Pregnancy * Co-morbid factors such as uncontrolled diabetes, ischemic heart disease, renal failure or Collagen vascular disease.
Contact & Investigator
Mohamed Abd Elmawla Mohamed, Resident plastic surgeon
✉ mohamed_abdelmageed@med.sohag.edu.eg📞 +0201221953861
Frequently Asked Questions
Who can join the NCT06488612 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 60 Years, studying Traumatic Skin Loss, 2nd and 3rd Degree Burn, Post Tumour Excision - Raw Areas Undergoes Split- Thickness Skin Grafts. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06488612 currently recruiting?
Yes, NCT06488612 is actively recruiting participants. Contact the research team at mohamed_abdelmageed@med.sohag.edu.eg for enrollment information.
Where is the NCT06488612 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06488612 clinical trial?
NCT06488612 is sponsored by Sohag University. The trial plans to enroll 20 participants.